Proteolytic inactivation of alpha‐1‐antitrypsin by human neutrophils: involvement of multiple and interlinked cell responses to phagocytosable targets
- 1 January 1994
- journal article
- Published by Wiley in European Journal of Clinical Investigation
- Vol. 24 (1) , 42-49
- https://doi.org/10.1111/j.1365-2362.1994.tb02058.x
Abstract
Neutrophil polymorphonuclear leukocytes (PMN) can inactivate the PMN-elastase inhibitor alpha-1-antitrypsin (A1AT) proteolytically, by using metalloproteinases normally stored as zymogens in myeloperoxidase (MPO)-negative granules. Supernatants from opsonized zymosan (OPZ)-triggered human PMN cleaved and inactivated human A1AT through a process inhibitable by metal-chelators, suggesting that the interaction of PMN with OPZ leads to the extracellular availability of active metalloenzymes. During OPZ-triggering, PMN used approximately 80% of the generated hydrogen peroxide (H2O2) to produce HOCl by means of the MPO pathway, while the remainder was catabolized by PMN themselves. No H2O2 was available as free compound in the extracellular environment and hydroxyl (.OH) or .OH-like radicals were not generated. The selective deletion of single components of the HOCl-generating MPO pathway resulted in the generation of PMN supernatants free of active metalloenzymes but rich of the corresponding zymogens. Similar results were obtained by replacing normal PMN with cells from a patient with hereditary MPO deficiency. No evidence was obtained for the intervention or contribution of .OH-like radicals, serine-proteinases and oxidized glutathione in the transformation of the zymogens into enzymes able to inactivate A1AT. On concluding, PMN undergoing phagocytosis release MPO in amount sufficient to handle the extracellular pool of the generated H2O2 entirely, leading to the generation of equimolar amounts of HOCl. In turn, HOCl or a similar compound derived from it interacts with concomitantly released metallozymogens, switching on their A1AT inactivating potential without the apparent contribution of other PMN-derived molecules.(ABSTRACT TRUNCATED AT 250 WORDS)Keywords
This publication has 30 references indexed in Scilit:
- Alpha 1-antitrypsin deficiency, emphysema, and liver disease. Genetic basis and strategies for therapy.Journal of Clinical Investigation, 1990
- Proteolytic inactivation of alpha-1-proteinase inhibitor by a neutrophil metalloproteinase.Journal of Clinical Investigation, 1988
- Oxidants spontaneously released by alveolar macrophages of cigarette smokers can inactivate the active site of alpha 1-antitrypsin, rendering it ineffective as an inhibitor of neutrophil elastase.Journal of Clinical Investigation, 1987
- Interaction of mouse macrophage elastase with native and oxidized human alpha 1-proteinase inhibitor.Journal of Clinical Investigation, 1987
- alpha 1-Antitrypsin: molecular pathology, leukocytes, and tissue damage.Journal of Clinical Investigation, 1986
- Myeloperoxidase as an effective inhibitor of hydroxyl radical production. Implications for the oxidative reactions of neutrophils.Journal of Clinical Investigation, 1986
- Regulation of alpha 1 proteinase inhibitor function by rabbit alveolar macrophages. Evidence for proteolytic rather than oxidative inactivation.Journal of Clinical Investigation, 1985
- Generation of nitrogen-chlorine oxidants by human phagocytes.Journal of Clinical Investigation, 1984
- In vitro suppression of serum elastase-inhibitory capacity by reactive oxygen species generated by phagocytosing polymorphonuclear leukocytes.Journal of Clinical Investigation, 1979
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970